Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
2000-2009
Title
Created Date
Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver
27 July 2014
Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis
19 December 2014
International Union of Pharmacology. LX. Retinoic acid receptors
18 December 2014
Genomic antagonism between retinoic acid and estrogen signaling in breast cancer
18 December 2014
Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells
18 December 2014
Endogenous melatonin and oxidatively damaged guanine in DNA
17 December 2014
Diverse actions of retinoid receptors in cancer prevention and treatment
17 December 2014
A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands
16 December 2014
Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer
12 December 2014
Case report: patient with multiple paragangliomas treated with long acting somatostatin analogue
08 December 2014
Display #
5
10
15
20
25
30
50
100
All
Page 81 of 111
Start
Prev
76
77
78
79
80
81
82
83
84
85
Next
End
Search
Follow us...
Latest
Melatonin and its ubiquitous anticancer effects
Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer
The impact of vitamin D on cancer: A mini review
Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy
Somatostatin and Somatostatin Receptors in Tumour Biology
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
Vitamin D Status in Pediatric Oncology Patients in Lebanon: A Comparison With Non-oncology Controls in a Case-Control Study
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis
Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Bibliography
Complete objective response to biological therapy of plurifocal breast carcinoma
How effective is chemo therapy?
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Vademecum
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer